These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 5418709)

  • 1. Calorimetric investigations of the binding of inhibitors to alpha-chymotrypsin. II. A systematic comparison of the thermodynamic functions of binding of a variety of inhibitors to alpha-chymotrypsin.
    Shiao DD
    Biochemistry; 1970 Mar; 9(5):1083-90. PubMed ID: 5418709
    [No Abstract]   [Full Text] [Related]  

  • 2. Calorimetric investigations of the binding of inhibitors to alpha-chymotrypsin. I. The enthalpy of dilution of alpha-chymotrypsin and of proflavin, and the enthalpy of binding of indole, N-acetyl-D-tryptophan, and proflavin to alpha-chymotrypsin.
    Shiao DD; Sturtevant JM
    Biochemistry; 1969 Dec; 8(12):4910-7. PubMed ID: 5391863
    [No Abstract]   [Full Text] [Related]  

  • 3. Thermodynamics of alpha-chymotrypsin-inhibitor complex formation. Effects of structural modification of the inhibitor.
    Hymes AJ; Cuppett CC; Canady WJ
    J Biol Chem; 1969 Feb; 244(4):637-43. PubMed ID: 5768861
    [No Abstract]   [Full Text] [Related]  

  • 4. Thermodynamics of alpha-chymotrypsin-substrate and inhibitor complex formation as a function of pH. Hydrophobic binding by the low and high pH forms of the enzyme.
    Cuppett CC; Canady WJ
    J Biol Chem; 1970 Mar; 245(5):1069-74. PubMed ID: 5417260
    [No Abstract]   [Full Text] [Related]  

  • 5. Methylation of histidine-57 in alpha-chymotrypsin by methyl p-nitrobenzenesulfonate. A new approach to enzyme modification.
    Nakagawa Y; Bender ML
    Biochemistry; 1970 Jan; 9(2):259-67. PubMed ID: 5460940
    [No Abstract]   [Full Text] [Related]  

  • 6. Low pH dimerization behavior of active-site derivatives of bovine -chymotrypsin.
    Horbett TA; Teller DC
    Biochemistry; 1973 Mar; 12(7):1349-58. PubMed ID: 4735302
    [No Abstract]   [Full Text] [Related]  

  • 7. The binding of inhibitors to alpha-chymotrypsin at alkaline pH.
    Johnson CH; Knowles JR
    Biochem J; 1967 May; 103(2):428-30. PubMed ID: 6032980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-phenylethaneboronic acid, a possible transition-state analog for chymotrypsin.
    Koehler KA; Lienhard GE
    Biochemistry; 1971 Jun; 10(13):2477-83. PubMed ID: 5557796
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduction of chymotrypsin A by dithiothreitol.
    Stanton M; Viswanatha T
    Can J Biochem; 1971 Nov; 49(11):1233-5. PubMed ID: 5134595
    [No Abstract]   [Full Text] [Related]  

  • 10. Consequences of the modification of tryptophan-215 on the function of bovine alpha-chymotrypsin.
    Keil-Dlouha V; Keil B
    J Mol Biol; 1973 Dec; 81(3):381-94. PubMed ID: 4797469
    [No Abstract]   [Full Text] [Related]  

  • 11. Binding of competitive inhibitors to delta-chymotrypsin in the alkaline pH region. Competitive inhibition kinetics and proton-uptake measurements.
    Valenzuela P; Bender ML
    Biochemistry; 1970 Jun; 9(12):2440-6. PubMed ID: 5423263
    [No Abstract]   [Full Text] [Related]  

  • 12. Conformational equilibria and the salt bridge in chymotrypsin.
    Fersht AR
    Cold Spring Harb Symp Quant Biol; 1972; 36():71-3. PubMed ID: 4508174
    [No Abstract]   [Full Text] [Related]  

  • 13. Preferential binding of competitive inhibitors to the monomeric form of -chymotrypsin.
    Nichol LW; Jackson WJ; Winzor DJ
    Biochemistry; 1972 Feb; 11(4):585-91. PubMed ID: 5011966
    [No Abstract]   [Full Text] [Related]  

  • 14. Modification of the amino group of isoleucine-16 in chymotrypsin with retention of activity.
    Agarwal SP; Martin CJ; Blair TT; Marini MA
    Biochem Biophys Res Commun; 1971 May; 43(3):510-5. PubMed ID: 5563303
    [No Abstract]   [Full Text] [Related]  

  • 15. Triazines and related products. 8. Potential irreversible chymotrypsin inhibitors: 3-alkyl-1,2,3-benzotriazin-4(3H)-ones and o-azidobenzamides.
    Mair AC; Stevens MF
    J Chem Soc Perkin 1; 1971; 12():2317-24. PubMed ID: 5104591
    [No Abstract]   [Full Text] [Related]  

  • 16. The topographical differences in the active site region of alpha-chymotrypsin, subtilisin Novo, and subtilisin Carlsberg. Mapping the aromatic binding site by inhibitors (virtual substrates).
    Bosshard HR; Berger A
    Biochemistry; 1974 Jan; 13(2):266-77. PubMed ID: 4810052
    [No Abstract]   [Full Text] [Related]  

  • 17. Structure of crystalline alpha-chymotrypsin. 3. Crystallographic studies of substrates and inhibitors bound to the active site of alpha-chymotrypsin.
    Steitz TA; Henderson R; Blow DM
    J Mol Biol; 1969 Dec; 46(2):337-48. PubMed ID: 5360043
    [No Abstract]   [Full Text] [Related]  

  • 18. Irreversible enzyme inhibitors. CXLV. Proteolytic enzymes. 8. Active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from alpha-(2-carboxy-4-chlorophenoxy)acetamide bearing a terminal sulfonyl fluoride.
    Baker BR; Hurlbut JA
    J Med Chem; 1969 Jan; 12(1):118-22. PubMed ID: 5763006
    [No Abstract]   [Full Text] [Related]  

  • 19. Ligand-induced pK changes in chymotrypsin.
    Glick DM
    Biochemistry; 1968 Oct; 7(10):3390-6. PubMed ID: 5681452
    [No Abstract]   [Full Text] [Related]  

  • 20. Interactions of alpha-chymotrypsin with peptides containing tryptophan or its derivatives at the C-terminus.
    Sato S; Karasaki Y; Ohno M
    J Biochem; 1977 Jul; 82(1):231-7. PubMed ID: 19455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.